Patent-Eligible Subject Matter

CLS Bank: A Deeply Divided En Banc Federal Circuit Fails to Rule When Computer Claims are Invalid Under 35 U.S.C. § 101

by Monte Cooper, Robert Isackson, William Benjamin Tabler | Orrick, Herrington & Sutcliffe LLP on 5/16/2013

On May 10, 2013, the en banc Federal Circuit issued its highly anticipated decision in CLS Bank Int’l v. Alice Corp. Pty. Ltd., No. 2011-1301, concerning whether computer-implemented method and system claims are patent...more

CLS Bank Int'l v. Alice Corp. (Fed. Cir. 2013) (en banc) -- Judge Lourie's Concurrence

by Michael Borella | McDonnell Boehnen Hulbert & Berghoff LLP on 5/16/2013

On May 10, the Federal Circuit handed down a much anticipated en banc ruling regarding the patent eligibility of computer-implemented inventions under 35 U.S.C. § 101. In a per curiam opinion that is perhaps the most...more

Patent Watch: CLS Bank Int'l v. Alice Corp.

by Lawrence M. Sung | BakerHostetler on 5/15/2013

[T]hough much is published today discussing the proper approach to the patent eligibility inquiry, nothing said today beyond our judgment has the weight of precedent....more

Federal Circuit Issues Decision on Section 101 Patent Eligibility of Computer-Implemented Inventions

by Eugene Mar, Stephanie Skaff, Rochelle Lee Woods | Farella Braun + Martel LLP on 5/15/2013

On May 10, 2013, the Federal Circuit issued its en banc decision in CLS Bank Int’l v. Alice Corp. (Case No. 2011-1301), a closely watched dispute regarding the standard for patent eligibility under 35 U.S.C. § 101. The per...more

En Banc Federal Circuit Issues Five Opinions in CLS Bank International v. Alice Corporation

by Paul Devinsky, Gregory Rabin | McDermott Will & Emery on 5/15/2013

The long-awaited decision held that method, computer-readable medium and system claims for technology related to “the management of risk relating to specified, yet unknown, future events” were not directed to patentable...more

Federal Circuit Fails to Set Clear Standard for Patent Eligibility

by C. Erik Hawes | Morgan Lewis on 5/14/2013

In an opinion that was poised to set a single standard governing the patent eligibility of computer-implemented inventions, no majority is reached....more

En Banc Decision in CLS Bank: No Clear Resolution for Eligibility of Computer-Related Inventions

by George Beck, Jeffrey Mikrut | Foley & Lardner LLP on 5/14/2013

On May 10, 2013, the Federal Circuit, sitting en banc,1 issued a per curiam decision in CLS Bank International v. Alice Corporation Pty. Ltd., No. 2011-1301, affirming that the asserted method, computer-readable media, and...more

NZ Clarifies Proposed Ban On Software Patents

by Carl Harrap, Joe Mok | Freehills Patent Attorneys on 5/14/2013

The NZ government yesterday released further amendments to tighten the proposed legislation around software patentability. The amendments clarify that while the partial ban on software patents is still on the agenda, it has...more

A Fractured Federal Circuit Creates More Questions Than Answers: CLS Bank Int’l v. Alice Corp., No. 2011-1301

by Jason Hall, Scott Llewellyn, Brian Matsui | Morrison & Foerster LLP on 5/14/2013

On Friday, the U.S. Court of Appeals for the Federal Circuit issued its en banc decision in CLS Bank Int’l v. Alice Corp. The decision includes seven separate opinions spanning 135 pages, but the only precedential portion...more

Federal Circuit Issues Fractured Affirmance in CLS Bank v. Alice Corporation

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 5/13/2013

In a fractured en banc decision, the Federal Circuit affirmed the district court’s holding that the claims at issue in CLS Bank v. Alice Corporation are invalid under 35 USC § 101. The multiple opinions reveal the judge’s...more

CLS Bank International v. Alice Corp.: Still No Definitive Guidance On Patent-Eligibility Under Section 101

by Rajiv Sarathy | Perkins Coie on 5/13/2013

On May 10, 2013, the U.S. Court of Appeals for the Federal Circuit released its much-awaited en banc decision in CLS Bank International v. Alice Corp. A majority of the court affirmed a district court's holding that Alice's...more

Dispelling the Myriad Gene Patent Harmonization Myth

by Courtenay C. Brinckerhoff | Foley & Lardner LLP on 5/1/2013

In the wake of the Supreme Court oral arguments in the Myriad “gene patent” case, most commentators are predicting that the Court will uphold the patent-eligibility of non-naturally occurring DNA sequences (such as cDNA), but...more

Supreme Debate: Are Human Genes Patentable?

by Therese Finan | Venable LLP on 5/1/2013

On April 15, 2013, tackling an issue of significant importance to the biotechnology and health care industries, the U.S. Supreme Court heard oral arguments over whether human genes are patentable and more specifically,...more

Don't Just Patent Everything, You Need To Have A Strategy

by Antonia Sequeira | Fenwick & West LLP on 4/29/2013

You can't patent it all. Inventors often want to patent every potentially novel detail of their technologies and patent attorneys are sometimes willing to help them do it. However, this type of unfocused, shotgun approach...more

Are Human Genes Patentable? Supreme Court Hears Oral Arguments in Myriad Case [Video]

by LXBN on 4/23/2013

The necessary balance between incentivizing and rewarding innovation with making those innovations widely available—and not stifling advancements by keeping competitors down—has been at the heart of patent law for some time....more

What We May Learn from the Myriad Oral Argument

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/19/2013

The U.S. Supreme Court heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. on Monday, and many have commented on the Court's interrogation of the parties' representatives (and the government)...more

Batting Practice with DNA Patents at the U.S. Supreme Court

by Heather Khassian, Karthika Perumal, Ph.D., Michael R. Samardzija, Ph.D. | Bracewell & Giuliani LLP on 4/17/2013

The Supreme Court heard oral arguments today in Association of Molecular Pathology vs. Myriad Genetics (Docket 12-398) regarding the patent eligibility of isolated DNA sequences. More specifically, they probed both parties in...more

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

by Marc Hearron, Matthew Kreeger, James J. Mullen, III | Morrison & Foerster LLP on 4/16/2013

Today, the Supreme Court of the United States heard oral argument in Association for Molecular Pathology v. Myriad Genetics, Inc. (No. 12-398) to decide the question, “Are human genes patentable?” The Court’s decision in...more

Myriad Genetic Database Under Siege

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/15/2013

With the U.S. Supreme Court set to consider the patent-eligibility of claims to isolated human DNA in AMP v. Myriad Genetics this morning, another aspect of Myriad’s control over BRCA testing technology is being contested. ...more

A Response to Dr. Mason's "Rebuttal" to Criticisms of His Genomics Medicine Article

by Kevin E. Noonan | McDonnell Boehnen Hulbert & Berghoff LLP on 4/12/2013

Much of the gene patenting debate has appeared, to experienced patent practitioners, to be akin to a conversation with Kevin Kline's character in A Fish Called Wanda, or perhaps a passage from P.G. Wodehouse's The Luck of the...more

Can You Patent Human Genes? ACLU Says No [Video]

by Bloomberg Law on 4/12/2013

April 12 (Bloomberg Law) -- On April 15, 2013, the United States Supreme Court will hear oral arguments for Association for Molecular Pathology v. Myriad Genetics, Inc. The case centers on whether patents may be granted on...more

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Patent-Eligible Subject Matter

CLS Bank: A Deeply Divided En Banc Federal Circuit Fails to Rule When Computer Claims are Invalid Under 35 U.S.C. § 101

CLS Bank Int'l v. Alice Corp. (Fed. Cir. 2013) (en banc) -- Judge Lourie's Concurrence

Patent Watch: CLS Bank Int'l v. Alice Corp.

Federal Circuit Issues Decision on Section 101 Patent Eligibility of Computer-Implemented Inventions

En Banc Federal Circuit Issues Five Opinions in CLS Bank International v. Alice Corporation

Federal Circuit Fails to Set Clear Standard for Patent Eligibility

En Banc Decision in CLS Bank: No Clear Resolution for Eligibility of Computer-Related Inventions

NZ Clarifies Proposed Ban On Software Patents

A Fractured Federal Circuit Creates More Questions Than Answers: CLS Bank Int’l v. Alice Corp., No. 2011-1301

Federal Circuit Issues Fractured Affirmance in CLS Bank v. Alice Corporation

CLS Bank International v. Alice Corp.: Still No Definitive Guidance On Patent-Eligibility Under Section 101

Dispelling the Myriad Gene Patent Harmonization Myth

Supreme Debate: Are Human Genes Patentable?

Don't Just Patent Everything, You Need To Have A Strategy

Are Human Genes Patentable? Supreme Court Hears Oral Arguments in Myriad Case [Video]

What We May Learn from the Myriad Oral Argument

Batting Practice with DNA Patents at the U.S. Supreme Court

After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules

Myriad Genetic Database Under Siege

A Response to Dr. Mason's "Rebuttal" to Criticisms of His Genomics Medicine Article

Can You Patent Human Genes? ACLU Says No [Video]

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

Genome Medicine Article Calls for Limits on Patenting of Existing Nucleotide Sequences

Supreme Court To Hear Oral Arguments in Landmark Patent Case

Is Lack of Preemption the Key for the Supreme Court to Decide in Myriad's Favor?

Are Human Genes Patentable? Supreme Court Hears Oral Arguments in Myriad Case [Video]

Can You Patent Human Genes? ACLU Says No [Video]

Yours, Mine and Ours (not yet!): An Update on the Patentability of Human Genes - [Video]

Expand Your Reach